Evidence map›Paper›PMID 41694559›Full record

ArticleFrontiers in endocrinology2026

Predicting resection success in giant pituitary adenomas: morphologic determinants and a preoperative multivariate model.

Dilan Ozaydin, Ender Vergili, Alperen Kaya, Ahmet Numan Demir, Pinar Kadioglu, Necmettin Tanriover

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dilan OzaydinDepartment of Neurosurgery, Stanford University, Palo Alto, CA, United States.
Ender VergiliDepartment of Neurosurgery, Istanbul University-Cerrahpaşa, Istanbul, Türkiye.
Alperen KayaDepartment of Neurosurgery, Istanbul University-Cerrahpaşa, Istanbul, Türkiye.
Ahmet Numan DemirDepartment of Endocrinology, Metabolism, and Diabetes, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
Pinar KadiogluDepartment of Endocrinology, Metabolism, and Diabetes, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
Necmettin TanrioverDepartment of Neurosurgery, Istanbul University-Cerrahpaşa, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Giant pituitary adenomas present significant therapeutic challenges due to their size, complex morphology, and frequent extension into critical neuroanatomical regions. Endoscopic transsphenoidal surgery (ETSS) has become the preferred first-line treatment, yet factors determining resectability remain incompletely defined. This study retrospectively analyzed 60 patients with giant pituitary adenomas treated via ETSS at a tertiary pituitary center to evaluate clinical characteristics, early surgical outcomes, and preoperative determinants of resection. Visual impairment was the most common presenting symptom and improved in 83.7% of patients. Based on early postoperative imaging, total or gross-total resection was achieved in 76.7% of the cohort, and permanent diabetes insipidus occurred in only 3.3%, with no major vascular or neurological complications observed. Larger tumor volume and maximum diameter, multilobulated morphology, cranial extension pattern, and higher Hardy grades were independently associated with limited resection. A multivariate model integrating volumetric, anatomical, and hormonal variables demonstrated moderate predictive accuracy for identifying patients at risk for subtotal resection (AUC = 0.745). These findings highlight the critical role of tumor geometry and extension patterns in determining the feasibility of complete removal and provide a practical framework for preoperative risk stratification. ETSS provides effective early tumor debulking in patients with giant pituitary adenomas; however, longer-term follow-up is required to fully assess the durability of surgical outcomes and disease control. Methods: We retrospectively analyzed 60 consecutive patients with giant pituitary adenomas who underwent endoscopic transsphenoidal surgery (ETSS) at a tertiary pituitary center between 2015 and 2023. Clinical, radiological, hormonal, and surgical variables were collected from medical records. Tumor volume, cranial extension pattern, Hardy and Knosp classifications, and multilobulated morphology were evaluated using preoperative MRI. Surgical outcomes, complications, and postoperative endocrine and visual results were recorded. Predictors of resection extent were assessed using multivariate logistic regression, and a preoperative prediction model was developed and evaluated with ROC analysis.

Indexed as

AdenomaPituitary NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedMultivariate AnalysisPrognosisRetrospective StudiesTreatment OutcomeTumor Burdencranial extensionendoscopic transsphenoidal surgerygiant pituitary adenomamultilobulated adenomaresection predictorstumor morphology

Identifiers

PMID41694559
PMCPMC12900767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.